mRNA vaccines greatly reduce COVID-19 infection risk for fully vaccinated: study
A health care worker prepares a dose of COVID-19 vaccine at a new vaccination site in the California Polytechnic State University in Pomona, Los Angeles County, California, the United States, Feb. 5, 2021. (Xinhua)
This study is among the first to show that mRNA vaccination benefits people who got COVID-19 despite being fully vaccinated or partially vaccinated, according to the study of the U.S. CDC.
WASHINGTON, June 7 (Xinhua) -- A new study published Monday finds the mRNA COVID-19 vaccines authorized by the U.S. Food and Drug Administration (FDA) reduce the risk of infection by 91 percent for fully vaccinated people.
The two FDA-approved mRNA COVID-19 vaccines are Pfizer-BioNTech vaccine and Moderna vaccine.
This study is among the first to show that mRNA vaccination benefits people who got COVID-19 despite being fully vaccinated or partially vaccinated, according to the study of the U.S. Centers for Disease Control and Prevention (CDC).
Fully vaccinated means 14 or more days after dose 2, and partially vaccinated refers to 14 or more days after dose 1 to 13 days after dose 2.
The findings came from four weeks of additional data collected in CDC's HEROES-RECOVER study of health care workers, first responders, frontline workers, and other essential workers. These groups are more likely to be exposed to the virus that causes COVID-19 because of their occupations.
"Findings from the extended timeframe of this study add to accumulating evidence that mRNA COVID-19 vaccines are effective and should prevent most infections - but that fully vaccinated people who still get COVID-19 are likely to have milder, shorter illness and appear to be less likely to spread the virus to others," said CDC Director Rochelle Walensky.
These benefits are another important reason to get vaccinated, she said.
Other study findings suggest that fully or partially vaccinated people who got COVID-19 might be less likely to spread the virus to others, according to the CDC.
Photos
Related Stories
- China approves COVID-19 vaccines for children above 3 years old
- Nation pushes overseas vaccine production
- China dispatches vaccine, syringe aid to 66 countries
- 21 COVID-19 vaccines enter clinical trials in China: official
- At least 70 pct of China's target population to be vaccinated by year end: official
Copyright © 2021 People's Daily Online. All Rights Reserved.